glp-1 gallbladder Does Cause Problems? Risks and Symptoms Gallbladder Risks with GLP-1 Medications

2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)

39 Gastrointestinal effects The most common adverse effect noted in clinical trials with GLP-1RA was gastrointestinal upset

Wegovys new pill is produced in North Carolina ( [16] ))

Exendin-4 increases absence-like seizures and anxietydepression-like behaviors in WAG/Rij rats

At the same time, various research and developments are also being conducted to identify new applications and to develop next-generation GLP-1 drugs